Literature DB >> 12850373

Recurrent genetic alterations in 26 colorectal carcinomas and 21 adenomas from Chinese patients.

Qiao-Jie He1, Wei-Fen Zeng, Jonathan S T Sham, Dan Xie, Xing-Wu Yang, Han-Liang Lin, Wen-Hua Zhan, Feng Lin, Sui-De Zeng, Daping Nie, Lin-Fei Ma, Chu-Jun Li, Shen Lu, Xin-Yuan Guan.   

Abstract

Colorectal cancer (CRC) is one of the most common malignancies worldwide. The incidence of CRC in the Chinese population has increased dramatically during the last two decades; however, nonrandom chromosomal alterations in Chinese patients have not been described. In the present study, comparative genomic hybridization (CGH) was applied to detect recurrent chromosome alterations in 26 primary colorectal carcinomas and 21 colorectal adenomas from Chinese patients. In CRC, several recurrent chromosomal changes were found, including gains of 8q (14/26 cases, 54%), 20q (54%), 3q (50%), 13q (50%), 5p (46%), 7p (42%), 7q (42%), and 12p (38%) and losses of 18q (65%) and 17p (42%). From comparison with previous CGH studies, the frequent gains of 3q and 12p might be distinctive occurrences in Chinese patients. The distribution of frequently found chromosomal alterations in different locations was studied. The gain of 20q was more frequently found in colon cancer (P<0.01) and the gain of 12p was more frequently found in rectal cancer. Chromosomal alterations were found in 19/21 of adenomas; the most frequent chromosomal alteration was the loss of 18q (9/21 cases, 43%). These recurrent alterations provide several starting points for the isolation of candidate oncogenes and tumor suppressor genes.

Entities:  

Mesh:

Year:  2003        PMID: 12850373     DOI: 10.1016/s0165-4608(02)00959-7

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  23 in total

1.  DNA copy number alterations, gene expression changes and disease-free survival in patients with colorectal cancer: a 10 year follow-up.

Authors:  Elisabetta Bigagli; Carlotta De Filippo; Cinzia Castagnini; Simona Toti; Francesco Acquadro; Francesco Giudici; Marilena Fazi; Piero Dolara; Luca Messerini; Francesco Tonelli; Cristina Luceri
Journal:  Cell Oncol (Dordr)       Date:  2016-10-05       Impact factor: 6.730

2.  Overexpression of EIF5A2 is associated with poor survival and aggressive tumor biology in gallbladder cancer.

Authors:  Xin Zheng; Lei Gao; Bo-Tao Wang; Ping Shen; Xiang-Fei Yuan; Lan-Qiu Zhang; Lei Yang; Da-Peng Zhang; Qi Zhang; Xi-Mo Wang
Journal:  Histol Histopathol       Date:  2019-11-20       Impact factor: 2.303

3.  HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancer.

Authors:  Khawla Al-Kuraya; Hedvika Novotny; Prashant Bavi; Abdul K Siraj; Shahab Uddin; Adnan Ezzat; Nasser Al Sanea; Fouad Al-Dayel; Hadeel Al-Mana; Salwa S Sheikh; Martina Mirlacher; Coya Tapia; Ronald Simon; Guido Sauter; Luigi Terracciano; Luigi Tornillo
Journal:  J Clin Pathol       Date:  2006-08-01       Impact factor: 3.411

4.  Human papillomavirus DNA and oncogene alterations in colorectal tumors.

Authors:  Luis Orlando Pérez; Gisela Barbisan; Anabel Ottino; Horacio Pianzola; Carlos Daniel Golijow
Journal:  Pathol Oncol Res       Date:  2010-03-17       Impact factor: 3.201

5.  Dominant expression of 85-kDa form of cortactin in colorectal cancer.

Authors:  Lian-Hai Zhang; Bo Tian; Li-Rong Diao; Yong-Yan Xiong; Su-Fang Tian; Bian-Hong Zhang; Wen-Mei Li; Hui Ren; Yan Li; Jia-Fu Ji
Journal:  J Cancer Res Clin Oncol       Date:  2005-10-28       Impact factor: 4.553

6.  Genome-wide copy number changes and CD133 expression characterized distinct subset of colon polyps: differentiation between incidental polyps and cancer-associated polyps.

Authors:  Chih-Yung Yang; Ju-Yu Tseng; Chian-Feng Chen; Teh-Ying Chou; Hong-Wei Gao; Chia-Ling Hua; Chi-Hung Lin; Jen-Kou Lin; Jeng-Kai Jiang
Journal:  Int J Colorectal Dis       Date:  2015-07-24       Impact factor: 2.571

7.  Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis.

Authors:  Austin M Dulak; Steven E Schumacher; Jasper van Lieshout; Yu Imamura; Cameron Fox; Byoungyong Shim; Alex H Ramos; Gordon Saksena; Sylvan C Baca; Jose Baselga; Josep Tabernero; Jordi Barretina; Peter C Enzinger; Giovanni Corso; Franco Roviello; Lin Lin; Santhoshi Bandla; James D Luketich; Arjun Pennathur; Matthew Meyerson; Shuji Ogino; Ramesh A Shivdasani; David G Beer; Tony E Godfrey; Rameen Beroukhim; Adam J Bass
Journal:  Cancer Res       Date:  2012-07-02       Impact factor: 12.701

8.  SKP2 overexpression is associated with a poor prognosis of rectal cancer treated with chemoradiotherapy and represents a therapeutic target with high potential.

Authors:  Yu-Feng Tian; Tzu-Ju Chen; Ching-Yih Lin; Li-Tzong Chen; Li-Ching Lin; Chung-Hsi Hsing; Sung-Wei Lee; Ming-Jen Sheu; Hao-Hsien Lee; Yow-Ling Shiue; Hsuan-Ying Huang; Hsin-Yi Pan; Chien-Feng Li; Shang-Hung Chen
Journal:  Tumour Biol       Date:  2013-01-18

9.  Distinct genetic alterations in colorectal cancer.

Authors:  Hassan Ashktorab; Alejandro A Schäffer; Mohammad Daremipouran; Duane T Smoot; Edward Lee; Hassan Brim
Journal:  PLoS One       Date:  2010-01-26       Impact factor: 3.240

10.  Transgenic CHD1L expression in mouse induces spontaneous tumors.

Authors:  Muhan Chen; Jian-dong Huang; Liang Hu; Bo-jian Zheng; Leilei Chen; Sze Lan Tsang; Xin-yuan Guan
Journal:  PLoS One       Date:  2009-08-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.